dihydroxyphenylalanine has been researched along with Hyperinsulinism, Familial, with Pancreatic Nesidioblastosis in 1 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Heide, LJ | 1 |
| Glaudemans, AW | 1 |
| Oomen, PH | 1 |
| Apers, JA | 1 |
| Totté, ER | 1 |
| van Beek, AP | 1 |
1 other study available for dihydroxyphenylalanine and Hyperinsulinism, Familial, with Pancreatic Nesidioblastosis
| Article | Year |
|---|---|
Functional imaging in hyperinsulinemic hypoglycemia after gastric bypass surgery for morbid obesity.
Topics: Adult; Carbon Radioisotopes; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Gastric Bypass; | 2012 |